LIGAND PHARMACEUTICALS INCORPORATED Accumulated Other Comprehensive Income
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Accumulated Other Comprehensive Income of $4.48 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-07
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $4.48M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $5.39M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.46M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $9.32M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | $4.48M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $5.39M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $8.46M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $9.32M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $8.49M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | -$1.56M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | -$5.94M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $1.75M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | -$935.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | -$910.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | -$817.00K 10-K · filed 2025-02-28 | |
| 2023-09-30 | -$944.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$967.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$935.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | -$984.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | -$1.06M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | -$1.07M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$1.03M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | -$917.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | -$875.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$861.00K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | -$856.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$801.00K 10-K · filed 2022-02-28 | |
| 2020-09-30 | -$1.44M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | -$2.31M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | -$4.87M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | -$216.00K 10-K · filed 2021-02-24 | |
| 2019-09-30 | -$1.49M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | -$542.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$503.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$1.02M 10-K · filed 2020-02-27 | |
| 2018-09-30 | -$64.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$151.00K 10-Q · filed 2018-08-08 | |
| 2018-03-31 | -$286.00K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $2.49M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $3.33M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.06M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $3.10M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $2.74M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $3.65M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $3.75M 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $3.57M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $4.90M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $5.56M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $11.27M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $9.33M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $4.95M 10-K · filed 2016-11-14 | $2.91M 10-K · filed 2014-12-01 |
| 2014-09-30 | $3.54M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $5.04M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $10.94M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $2.91M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $2.20M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $1.40M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $1.17M 10-Q · filed 2013-05-08 | |
| 2011-06-30 | $0.00 10-Q/A · filed 2012-02-10 | |
| 2010-12-31 | $31.00K 10-K/A · filed 2012-11-14 |